213 related articles for article (PubMed ID: 26773505)
21. A yeast expression system for human galactose-1-phosphate uridylyltransferase.
Fridovich-Keil JL; Jinks-Robertson S
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):398-402. PubMed ID: 8421669
[TBL] [Abstract][Full Text] [Related]
22. The structural and molecular biology of type I galactosemia: Enzymology of galactose 1-phosphate uridylyltransferase.
McCorvie TJ; Timson DJ
IUBMB Life; 2011 Sep; 63(9):694-700. PubMed ID: 21793161
[TBL] [Abstract][Full Text] [Related]
23. Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase.
Riehman K; Crews C; Fridovich-Keil JL
J Biol Chem; 2001 Apr; 276(14):10634-40. PubMed ID: 11152465
[TBL] [Abstract][Full Text] [Related]
24. A Drosophila melanogaster model of classic galactosemia.
Kushner RF; Ryan EL; Sefton JM; Sanders RD; Lucioni PJ; Moberg KH; Fridovich-Keil JL
Dis Model Mech; 2010; 3(9-10):618-27. PubMed ID: 20519569
[TBL] [Abstract][Full Text] [Related]
25. The molecular basis of galactosemia - Past, present and future.
Timson DJ
Gene; 2016 Sep; 589(2):133-41. PubMed ID: 26143117
[TBL] [Abstract][Full Text] [Related]
26. Receptor-mediated attenuation of insulin-like growth factor-1 activity by galactose-1-phosphate in neonate skin fibroblast cultures: Galactosemia pathogenesis.
Al-Essa M; Dhaunsi G
Adv Clin Exp Med; 2020 Apr; 29(4):499-504. PubMed ID: 32356415
[TBL] [Abstract][Full Text] [Related]
27. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
28. Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I.
Matthews LC; Taggart MJ; Westwood M
Endocrinology; 2008 Oct; 149(10):5199-208. PubMed ID: 18583416
[TBL] [Abstract][Full Text] [Related]
29. Galactose and glucose metabolism in galactokinase deficient, galactose-1-P-uridyl transferase deficient and normal human fibroblasts.
Friedman TB; Yarkin RJ; Merril CR
J Cell Physiol; 1975 Jun; 85(3):569-78. PubMed ID: 167035
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and molecular characterization of GALT gene from Indian galactosemia patients: identification of 10 novel mutations and their structural and functional implications.
Singh R; Thapa BR; Kaur G; Prasad R
Clin Chim Acta; 2012 Dec; 414():191-6. PubMed ID: 23022339
[TBL] [Abstract][Full Text] [Related]
31. Grip strength in patients with galactosemia and in a galactose-1-phosphate uridylyltransferase (GALT)-null rat model.
Druss JJ; Rudd Zhong Manis J; Potter NL; Fridovich-Keil JL
J Inherit Metab Dis; 2023 Nov; 46(6):1131-1138. PubMed ID: 37776278
[TBL] [Abstract][Full Text] [Related]
32. PI3K-Akt-mTOR signal inhibition affects expression of genes related to endoplasmic reticulum stress.
Song Q; Han CC; Xiong XP; He F; Gan W; Wei SH; Liu HH; Li L; Xu HY
Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525855
[TBL] [Abstract][Full Text] [Related]
33. GALT Deficiency Galactosemia.
Anderson S
MCN Am J Matern Child Nurs; 2018; 43(1):44-51. PubMed ID: 29215423
[TBL] [Abstract][Full Text] [Related]
34. Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia?
Berry GT
J Inherit Metab Dis; 2011 Apr; 34(2):345-55. PubMed ID: 21246399
[TBL] [Abstract][Full Text] [Related]
35. Neonatal GALT gene replacement offers metabolic and phenotypic correction through early adulthood in a rat model of classic galactosemia.
Daenzer JMI; Rasmussen SA; Patel S; McKenna J; Fridovich-Keil JL
J Inherit Metab Dis; 2022 Mar; 45(2):203-214. PubMed ID: 34964137
[TBL] [Abstract][Full Text] [Related]
36. Early postnatal alterations in follicular stress response and survival in a mouse model of Classic Galactosemia.
Hagen-Lillevik S; Johnson J; Lai K
J Ovarian Res; 2022 Nov; 15(1):122. PubMed ID: 36414970
[TBL] [Abstract][Full Text] [Related]
37. Fluorinated Galactoses Inhibit Galactose-1-Phosphate Uridyltransferase and Metabolically Induce Galactosemia-like Phenotypes in HEK-293 Cells.
Janes V; Grabany S; Delbrouck J; Vincent SP; Gottschalk J; Elling L; Hanisch FG
Cells; 2020 Mar; 9(3):. PubMed ID: 32138379
[TBL] [Abstract][Full Text] [Related]
38. Akt activation and augmented fibronectin production in hyperhexosemia.
Xin X; Chen S; Khan ZA; Chakrabarti S
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1036-44. PubMed ID: 17666488
[TBL] [Abstract][Full Text] [Related]
39. Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway.
Li XT; Liang Z; Wang TT; Yang JW; Ma W; Deng SK; Wang XB; Dai YF; Guo JH; Li LY
CNS Neurol Disord Drug Targets; 2017; 16(7):828-836. PubMed ID: 28524001
[TBL] [Abstract][Full Text] [Related]
40. Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor.
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2011 Jun; 660(2-3):341-50. PubMed ID: 21515255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
